From people -
for people
Octapharma - clicking the octapharma logo will load the homepage
Terms of use
Octapharma News
The Company
Products & Therapeutic Areas
Research & Development
Production
Safety & Quality
Carefully Selected Donor Centres
Selection of Plasma Donors
High Quality Plasma
Incoming Plasma Control
Small Plasma Batches
Virus Inactivation
Good Manufacturing Practise
Quality Control
Batch Release
Controlled Storage and Shipment
Clinical Evaluation
Pharmacovigilance
Stockholm Plant
Vienna Plant
Lingolsheim Plant
Worldwide Contacts
Employment Opportunities
Expand Menu

 

Pharmacovigilance

Pharmacovigilance describes the process of monitoring quality, safety, and efficacy of licensed drugs

Octapharma´s Drug Safety Unit has established a robust system to collect, collate, evaluate and report to the competent authorities, all information about suspected adverse reactions.

In addition, Octapharma publishes Periodic Safety Update Reports on all products, which include:
  • all relevant new clinical & non-clinical safety data
  • cumulative patient exposure data
  • adverse reaction data
  • summary of marketing authorisations / regulatory status

Octapharma also conducts a number of clinical pharmacovigilance / post-marketing studies to provide a comprehensive picture of clinical safety and efficacy.